• 1
    Johansson SL, Cohen SM. Epidemiology and etiology of bladder cancer. Semin Surg Oncol 1997; 13: 2918.
  • 2
    Phillips DH. Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 2002; 23: 19792004.
  • 3
    Kogevinas M, Trichopoulos D. Urinary bladder cancer. In: AdamiHO, HunterD, TrichopoulosD, eds. Textbook of cancer epidemiology. New York: Oxford University Press, 2002. 44666.
  • 4
    Pryor WA, Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 1993; 686: 1227; discussion 27–8.
  • 5
    Abdi S, Ali A. Role of ROS modified human DNA in the pathogenesis and etiology of cancer. Cancer Lett 1999; 142: 19.
  • 6
    Lindahl T. Recognition and processing of damaged DNA. J Cell Sci Suppl 1995; 19: 737.
  • 7
    Bennett RA, Wilson DM,III, Wong D, Demple B. Interaction of human apurinic endonuclease and DNA polymerase beta in the base excision repair pathway. Proc Natl Acad Sci USA 1997; 94: 71669.
  • 8
    Mitra S, Hazra TK, Roy R, Ikeda S, Biswas T, Lock J, Boldogh I, Izumi T. Complexities of DNA base excision repair in mammalian cells. Mol Cells 1997; 7: 30512.
  • 9
    Izumi T, Hazra TK, Boldogh I, Tomkinson AE, Park MS, Ikeda S, Mitra S. Requirement for human AP endonuclease 1 for repair of 3′-blocking damage at DNA single-strand breaks induced by reactive oxygen species. Carcinogenesis 2000; 21: 132934.
  • 10
    Hadi MZ, Coleman MA, Fidelis K, Mohrenweiser HW, Wilson DM,III. Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res 2000; 28: 38719.
  • 11
    Wilson DM,III, Sofinowski TM, McNeill DR. Repair mechanisms for oxidative DNA damage. Front Biosci 2003; 8: d96381.
  • 12
    Suh D, Wilson DM,III, Povirk LF. 3′-phosphodiesterase activity of human apurinic/apyrimidinic endonuclease at DNA double-strand break ends. Nucleic Acids Res 1997; 25: 2495500.
  • 13
    Ramana CV, Boldogh I, Izumi T, Mitra S. Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc Natl Acad Sci USA 1998; 95: 50616.
  • 14
    Wilson DM,III, Takeshita M, Grollman AP, Demple B. Incision activity of human apurinic endonuclease (Ape) at abasic site analogs in DNA. J Biol Chem 1995; 270: 160027.
  • 15
    Breen AP, Murphy JA. Reactions of oxyl radicals with DNA. J Free Radic Biol Med 1995; 18: 103377.
  • 16
    Sancar A. DNA repair in humans. Annu Rev Genet 1995; 29: 69105.
  • 17
    Kelley MR, Cheng L, Foster R, Tritt R, Jiang J, Broshears J, Koch M. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res 2001; 7: 82430.
  • 18
    Au WW, Salama SA, Sierra-Torres CH. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect 2003; 111: 184350.
  • 19
    Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case LD. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 2001; 22: 91722.
  • 20
    Ito H, Matsuo K, Hamajima N, Mitsudomi T, Sugiura T, Saito T, Yasue T, Lee KM, Kang D, Yoo KY, Sato S, Ueda R, et al. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis 2004; 25: 1395401.
  • 21
    Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, Drings P, Bartsch H, Schmezer P. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 2004; 25: 243341.
  • 22
    Misra RR, Ratnasinghe D, Tangrea JA, Virtamo J, Andersen MR, Barrett M, Taylor PR, Albanes D. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett 2003; 191: 1718.
  • 23
    Vineis P. Molecular epidemiology: low-dose carcinogens and genetic susceptibility. Int J Cancer 1997; 71: 13.
  • 24
    Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 1991; 51: 517780.
  • 25
    Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993; 85: 115964.
  • 26
    Taylor JA, Umbach DM, Stephens E, Castranio T, Paulson D, Robertson C, Mohler JL, Bell DA. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res 1998; 58: 360310.
  • 27
    Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2001; 10: 12531.
  • 28
    Lindahl T. Keynote: past, present, and future aspects of base excision repair. Prog Nucleic Acid Res Mol Biol 2001; 68: xviixxx.